BTCC
/
BTCC Square
/
CoindeskEN
/
South Korean Biotech Firm Secures $183.3M to Fuel Bold Bitcoin Treasury Strategy
South Korean Biotech Firm Secures $183.3M to Fuel Bold Bitcoin Treasury Strategy
10
3
In a move that blurs the lines between biotech and blockchain, a South Korean firm just bet big on Bitcoin’s future—with Wall Street-style swagger.
The $183.3 Million Gamble
The company—better known for pipettes than price charts—just landed a nine-figure funding round. Their play? Diversify into digital assets while traditional finance scrambles to keep up.
Why Bitcoin? Why Now?
With institutional adoption surging, even labs are hedging against fiat. The biotech’s pivot mirrors MicroStrategy’s playbook—minus the CFO’s existential tweets.
The Cynical Take
Because nothing says ‘breakthrough innovation’ like chasing the asset that turns CFOs into part-time meme lords.
By:
